Literature DB >> 10772493

Ataxia and paresis with equine herpesvirus type 1 infection in a herd of riding school horses.

P A Friday1, W K Scarratt, F Elvinger, P J Timoney, A Bonda.   

Abstract

An outbreak of neurologic disease associated with serologic evidence of equine herpesvirus type 1 (EHV-1) infection occurred in a herd of 46 riding school horses. Ataxia and paresis were observed in 14 geldings and 5 barren mares. Eight affected horses had distal limb edema, 1 horse had a head tilt, and 3 others had urinary incontinence. Other clinical signs included fever, depression, and inappetance in 30 horses. Seven horses with neurologic signs were treated with acyclovir. Serum neutralizing antibody titers against EHV-1 increased 4-fold between acute and convalescent samples or exceeded 1:256 in 19 of 44 horses, confirming recent infection. A significantly greater proportion of horses that seroconverted were mares (P = .014). Of the 19 horses exhibiting ataxia and paresis, 17 made a complete recovery, 1 made a partial recovery, and 1 was euthanized.

Entities:  

Mesh:

Year:  2000        PMID: 10772493     DOI: 10.1892/0891-6640(2000)014<0197:aapweh>2.3.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  8 in total

1.  Investigation of the Use of Non-Invasive Samples for the Molecular Detection of EHV-1 in Horses with and without Clinical Infection.

Authors:  Danielle Price; Samantha Barnum; Jenny Mize; Nicola Pusterla
Journal:  Pathogens       Date:  2022-05-13

2.  Oral Administration of Valganciclovir Reduces Clinical Signs, Virus Shedding and Cell-Associated Viremia in Ponies Experimentally Infected with the Equid Herpesvirus-1 C2254 Variant.

Authors:  Côme J Thieulent; Gabrielle Sutton; Marie-Pierre Toquet; Samuel Fremaux; Erika Hue; Christine Fortier; Alexis Pléau; Alain Deslis; Stéphane Abrioux; Edouard Guitton; Stéphane Pronost; Romain Paillot
Journal:  Pathogens       Date:  2022-05-04

3.  Pharmacokinetics of acyclovir after intravenous infusion of acyclovir and after oral administration of acyclovir and its prodrug valacyclovir in healthy adult horses.

Authors:  B Garré; K Shebany; A Gryspeerdt; K Baert; K van der Meulen; H Nauwynck; P Deprez; P De Backer; S Croubels
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

4.  Detection of the neuropathogenic variant of equine herpesvirus 1 associated with abortions in mares in Poland.

Authors:  Karol Stasiak; Jerzy Rola; Gabor Ploszay; Wojciech Socha; Jan F Zmudzinski
Journal:  BMC Vet Res       Date:  2015-05-01       Impact factor: 2.741

5.  Failure to detect equid herpesvirus types 1 and 4 DNA in placentae and healthy new-born Thoroughbred foals.

Authors:  Lara J Brown; Geoff Brown; Julia Kydd; Tom A E Stout; Martin L Schulman
Journal:  J S Afr Vet Assoc       Date:  2019-05-30       Impact factor: 1.474

Review 6.  EHV-1: A Constant Threat to the Horse Industry.

Authors:  Fatai S Oladunni; David W Horohov; Thomas M Chambers
Journal:  Front Microbiol       Date:  2019-12-03       Impact factor: 5.640

7.  Apparent Breed Predilection for Equid Herpesvirus-1-Associated Myeloencephalopathy (EHM) in a Multiple-Breed Herd.

Authors:  Eva Klouth; Yury Zablotski; Lutz S Goehring
Journal:  Pathogens       Date:  2021-04-29

8.  Molecular Monitoring of EHV-1 in Silently Infected Performance Horses through Nasal and Environmental Sample Testing.

Authors:  Nicola Pusterla; Samantha Barnum; Amy Young; Eric Mendonsa; Steve Lee; Steve Hankin; Skyler Brittner; Carrie J Finno
Journal:  Pathogens       Date:  2022-06-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.